Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Bausch + Lomb Corporation

BLCONYSE
Healthcare
Medical - Instruments & Supplies
$17.99
$0.05(0.28%)
U.S. Market opens in 15h 27m

Bausch + Lomb Corporation Fundamental Analysis

Bausch + Lomb Corporation (BLCO) shows moderate financial fundamentals with a PE ratio of -17.66, profit margin of -7.06%, and ROE of -5.61%. The company generates $5.1B in annual revenue with strong year-over-year growth of 15.15%.

Key Strengths

Current Ratio1.55

Areas of Concern

ROE-5.61%
Operating Margin3.12%
We analyze BLCO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 23.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
23.4/100

We analyze BLCO's fundamental strength across five key dimensions:

Efficiency Score

Weak

BLCO struggles to generate sufficient returns from assets.

ROA > 10%
-2.57%

Valuation Score

Excellent

BLCO trades at attractive valuation levels.

PE < 25
-17.66
PEG Ratio < 2
1.02

Growth Score

Moderate

BLCO shows steady but slowing expansion.

Revenue Growth > 5%
15.15%
EPS Growth > 10%
-21.62%

Financial Health Score

Excellent

BLCO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.83
Current Ratio > 1
1.55

Profitability Score

Weak

BLCO struggles to sustain strong margins.

ROE > 15%
-560.79%
Net Margin ≥ 15%
-7.06%
Positive Free Cash Flow
No

Key Financial Metrics

Is BLCO Expensive or Cheap?

P/E Ratio

BLCO trades at -17.66 times earnings. This suggests potential undervaluation.

-17.66

PEG Ratio

When adjusting for growth, BLCO's PEG of 1.02 indicates fair valuation.

1.02

Price to Book

The market values Bausch + Lomb Corporation at 0.99 times its book value. This may indicate undervaluation.

0.99

EV/EBITDA

Enterprise value stands at 2.41 times EBITDA. This is generally considered low.

2.41

How Well Does BLCO Make Money?

Net Profit Margin

For every $100 in sales, Bausch + Lomb Corporation keeps $-7.06 as profit after all expenses.

-7.06%

Operating Margin

Core operations generate 3.12 in profit for every $100 in revenue, before interest and taxes.

3.12%

ROE

Management delivers $-5.61 in profit for every $100 of shareholder equity.

-5.61%

ROA

Bausch + Lomb Corporation generates $-2.57 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.57%

Following the Money - Real Cash Generation

Operating Cash Flow

Bausch + Lomb Corporation generates limited operating cash flow of $283.70M, signaling weaker underlying cash strength.

$283.70M

Free Cash Flow

Bausch + Lomb Corporation generates weak or negative free cash flow of $-62.74M, restricting financial flexibility.

$-62.74M

FCF Per Share

Each share generates $-0.18 in free cash annually.

$-0.18

FCF Yield

BLCO converts -0.99% of its market value into free cash.

-0.99%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-17.66

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

1.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.99

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.25

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.83

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.55

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.06

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

0.01

vs 25 benchmark

How BLCO Stacks Against Its Sector Peers

MetricBLCO ValueSector AveragePerformance
P/E Ratio-17.6629.28 Better (Cheaper)
ROE-5.61%820.00% Weak
Net Margin-7.06%-19743.00% (disorted) Weak
Debt/Equity0.830.26 Weak (High Leverage)
Current Ratio1.554.69 Neutral
ROA-2.57%-17807.00% (disorted) Weak

BLCO outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Bausch + Lomb Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

25.72%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-205.83%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-71.11%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ